International E-publication: Publish Projects, Dissertation, Theses, Books, Souvenir, Conference Proceeding with ISBN.  International E-Bulletin: Information/News regarding: Academics and Research

Nosocomial Klebsiella infection and its virulence factor associated with drug resistance

Author Affiliations

  • 1Department of Microbiology, Yenepoya Medical College, Mangalore, Karnataka, India
  • 2Department of Microbiology, Yenepoya Medical College, Mangalore, Karnataka, India

Int. Res. J. Biological Sci., Volume 6, Issue (4), Pages 48-54, April,10 (2017)

Abstract

Klebsiella species are gram negative bacilli; non-motile bacteria belong to the Enterobacteriaceae family. They are opportunistic pathogens responsible for diseases like urinary tract infection, pneumonia, septicemia, meningitis and soft tissue infections. Chromosomal mutation in the DNA gyrase and DNA topoisomerase IV leads to the plasmid mediated quinolone resistance (PMQR) in Klebsiella spp. The Klebsiella spp. primarily isolated from different clinical samples by the conventional methods. Isolates are further identified by standard biochemical methods and susceptibility testing of PMQR along with MIC is determined by the CLSI guidelines. Phenotypically type 1 and 3 fimbriae can be determined by the hemagglutination assays. Genotypic methods have been proved to be a great tool for detection of virulence and drug resistance genes associated with the Klebsiella infection. This studyalso focus on the virulence factors and most common drug resistant mechanism for quinolone group of antibiotics used in treatment of Klebsiella infection.

References

  1. Montgomerie J.Z. (1979)., Epidemiology of Klebsiella and hospital-associated infections., Rev Infect disease., 1(5), 736-53.
  2. Jarvis W.R., Munn V.P., Highsmith A.K., Culver D.H. and Hughes J.M. (1985)., The epidemiology of nosocomial infections caused by Klebsiella pneumoniae., Infection Control, 6(2), 68-74.
  3. Podschun R. and Ullmann U. (1998)., Klebsiella spp. as nosocomial pathogens: epidemiology, taxonomy, typing methods and Pathogenicity factors., Clinical Microbiology Review, 11(4), 589-603.
  4. Schwaber M.J. and Carmeli Y. (2007)., Mortality and delay in effective therapy associated with extended-spectrum beta lactamase production in Enterobacteriaceae bacteremia: a systematic review and meta-analysis., Journal of Antimicrobial Chemotherapy, 60(5), 913-20.
  5. Giske C.G., Monnet D.L., Cars O. and Carmeli Y. (2008)., Re Act- Action on Antibiotic R. Clinical and economic impact of common multidrug-resistant gram negative bacilli., Antimicrobial Agents and Chemotherapy, 52(3), 813-821.
  6. Chuang Y.P., Fang C.T., Lai S.Y., Chang S.C. and Wang J.T. (2006)., Genetic determinants of capsular serotype K1 of K. pneumoniae causing primary pyogenic liver abscess., Journal of Infectious Disease, 193(5), 645-654.
  7. Balestrino D., Ghigo M., Charbonnel N., Haagensen J.A. and Forestier C. (2008)., The characterization of functions involved in the establishment and maturation of K. pneimoniae in vitro biofilm reveals dual roles for surface exopolysaccharides., Environmental Microbiology. 10(3), 685-701.
  8. Podschun R. and Ullmann U. (1998)., Klebsiella spp. as Nosocomial Pathogens: Epidemiology, Taxonomy,Typing Methods, and Pathogenicity Factors., Clinical Microbiology Reviews, 11(4), 589-603.
  9. Olaya R., Christophe B., Latour-Lambert P. and Ghigo J.M. (2014)., A new biofilm-associated colicin with increased efficiency against biofilm bacteria., International Society for Microbial Ecology, 8(6), 1275-1288.
  10. Gerlach G.F., Clegg S. and Allen B.L. (1989)., Identification and characterization of the genes encoding the type 3 and type 1 fimbrial adhesins of Klebsiella pneumoniae., J. Bacteriol., 171(3), 1262-1270.
  11. Ottow J.C. (1975)., Ecology, physiology, and genetics of fimbriae and pili., Annu. Rev. Microbiol. 29(1), 79-108.
  12. Stahlhut S.G., Chattopadhyay S., Struve C., Weissman S.J., Aprikian P. and Libby S.J. and Fang Ferric C., Krogfelt Karen Angeliki, Sokurenko Evgeni V. (2009)., Population Variability of the FimH Type 1 Fimbrial Adhesin in Klebsiella pneumonia., Journal of Bacteriology, 191(6), 1941-1950.
  13. Mulvey M.A., Lopez-Boado Y.S., Wilson C.L., Roth R., Parks W.C., Heuser J. and Hultgren S.J. (1998)., Induction and evasion of host defenses by type 1-piliated uropathogenic Escherichia coli., Science, 282(5393), 1494-1497.
  14. Reisner Andreas, Maierl Mario, Jörger Michael, Krause Robert, Berger Daniela, Haid Andrea, Tesic Dijana and Zechner Ellen L. (2014)., Type 1 Fimbriae Contribute to Catheter-Associated Urinary Tract Infections Caused by Escherichia coli., Journal of Bacteriology, 196(5), 931-939.
  15. Stahlhut Steen G., Chattopadhyay Sujay, Struve Carsten, Weissman Scott J., Aprikian Pavel, Libby Stephen J., Fang Ferric C., Krogfelt Karen Angeliki, Sokurenko Evgeni V.(2009)., Population Variability of the FimH Type 1 Fimbrial Adhesin in Klebsiella pneumoniae., Journal of Bacteriology, 191(6), 1941-1950 .
  16. Kil soo ki, Rabhi O. Darouiche, Richard A. Hull and Mohammad D. (1997)., Mansouri and Daniel M. Musher. Identification of a Klebsiella pneumoniae Strain Associated with Nosocomial Urinary Tract Infection., Journal of clinical microbiology, 35(9), 2370-2374.
  17. Cubero M., Grau I., Tubau F., Pallares R., Dominguez M.A. and Linares J. and Ardanuy C. (2015)., Hypervirulent Klebsiella pneumoniae clones causing bacteraemia in adultsin a teaching hospital in Barcelona, Spain., Clinical Microbiology and Infection, 22(2), 154-160.
  18. Jawetz Melnick and Adelberg’s Medical Microbiology (2010)., Antimicrobial Chemotherapy., International 25th Edition, 339-372, ISBN: 978-0-07-162496-1.
  19. Raei Fereshteh, Eftekhar Fereshteh and Feizabadi Mohammad Mehdi (2014)., Prevalence of Quinolone Resistance Among Extended-Spectrum β-Lactamase Producing Uropathogenic Klebsiella pneumoniae., Jundishapur Journal of Microbiology, 7(6), 1-5.
  20. Winn W.C. (2006)., Koneman’s color atlas and textbook of diagnostic Microbiology., 6th ed. Philadelphia. Lippincott Williams and Wilkins. International 5th Edition. ISBN:0-397-51529-4.
  21. Abdel H.H., Hawas S., Ei-Daker M. and Ei-Kad R. (2008)., Extended-spectrum b-lactamase producing Klebsiella pneumoniae in neonatal intensive care unit., Journal of Perinatology, 28, 685-690.
  22. Tribuddharat Chanwit, Srifuengfung Somporn and Chiangjong Wararat (2007)., A Correlation between Phenotypes and Genotypes of Extended-Spectrum Beta-Lactamase (ESBL) Producing Klebsiella pneumoniae in a University Hospital, Thailand., Journal Infectious Disease Antimicrobial Agents, 24, 117-123.
  23. Yang Jiyong, Luo Yanping, Cui Shenghui, Wang Weiwei and Han Li (2011)., Diverse Phenotypic and Genotypic Characterization among Clinical Klebsiella pneumoniae and Escherichia coli Isolates Carrying Plasmid-Mediated Quinolone Resistance Determinants., Microbial Drug Resistance, 17(3), 363-367.
  24. Shah R.K., Singh Y.I., Sanjana R.K., Chaudhary Navin and Saldanha Dominic (2010)., Extended spectrum β-lactamases (ESBLs) producing Klebsiella species in various clinical specimens: A preliminary report., Journal of College of Medical Sciences Nepal, 6(3), 18-23.
  25. Singhal S., Mathur T., Khan S., Upadhyay D.J., Chugh S., Gaind R. and Rattan A. (2005)., Evaluation of methods for AmpC β-lactamase in Gram negative clinical isolates from tertiary care hospitals., Indian Journal Medical Microbiology, 23(2), 120-124.
  26. Khurana S., Taneja Neelam, Sharma Meera (2002)., Extended spectrum β-lactamase mediated resistance in urinary isolates of family Enterobacteriaceae., Indian Journal of Medical Research, 116, 145-149.
  27. Seo M.R., Soo Park Yoon and Pai Hyunjoo (2010)., Characteristics of Plasmid-Mediated Quinolone Resistance Genes in Extended-Spectrum Cephalosporin-Resistant Isolates of K. pneumoniae and Escherichia coli in Korea., Chemotherapy, 56(1), 46-53.
  28. Hoşgör-Limoncu Mine, Eraç Bayrı, Yurtman Ayşe Nur and Aydemir Şöhret (2012)., Plasmid mediated quinolone resistance mechanisms in ESBL positive Escherichia coli and Klebsiella pneumoniae strains at a Tertiary-Care Hospital in Turkey., Journal of Chemotherapy, 24(3), 144-149.
  29. Yang Hong, Chen Hongbin, Yang Qiwen, Chen Minjun and Wang Hui (2008)., High Prevalence of Plasmid-Mediated Quinolone Resistance Genes qnr and aac(6)-Ib-cr in Clinical Isolates of Enterobacteriaceae from Nine Teaching Hospitals in China., Antimicrobial Agents and Chemotherapy, 52(12), 4268–4273.
  30. Goudarzi Mehdi, Azad Mehdi and Seyedjavadi Sima Sadat (2015)., Prevalence of Plasmid-Mediated Quinolone Resistance Determinants and OqxAB Efflux Pumps among Extended-Spectrum 𝛽-Lactamase Producing Klebsiella pneumoniae Isolated from Patients with Nosocomial Urinary Tract Infection in Tehran, Iran., Scientifica, 1-7.
  31. Kim Hong Bin, Park Chi Hye, Kim Chung Jong, Kim Eui-Chong, Jacoby George A. and Hooper David C. (2009)., Prevalence of Plasmid-Mediated Quinolone Resistance Determinants over a 9-Year Period., Antimicrobial Agents and Chemotherapy, 53(2), 639-645.
  32. Plasmid mediated drug resistance/ images., undefined, undefined
  33. Silva-Sanchez Jesus, Barrios Humberto, Reyna-Flores Fernando, Bello-Diaz Margarita, Sanchez-Perez Alejandro, Rojas Teresa, Consortium Bacterial Resistance, Garza-Ramos Ulises. (2011)., Prevalence and Characterization of Plasmid-Mediated Quinolone Resistance Genes in Extended-Spectrum b-Lactamase–Producing Enterobacteriaceae Isolates in Mexico., Microbial drug resistance, 17(4), 497-505.
  34. Rodriguez-Martinez Jose-Manuel, Poirel Laurent, Pascual Alvaro and Nordmann Patrice (2006)., Plasmid-Mediated Quinolone Resistance in Australia., Microbial Drug Resistance, 12(2), 99-102.
  35. Lin Chi-Jan, Siu Kristopher L., Ma Ling, Chang Ya-Ting, Lu Po-Liang (2012)., Molecular Epidemiology of Ciprofloxacin-Resistant Extended-Spectrum b-Lactamase–Producing Klebsiella pneumoniae in Taiwan., Microbial drug resistance, 18(1), 52-58.
  36. Tamang Migma Dorji, Seol Sung Yong, Oh Jae-Young, Kang Hee Young, Lee Je Chul, Lee Yoo Chul, Cho Dong Taek and Kim Jungmin (2008)., Plasmid Mediated Quinolone Resistance Determinants qnrA, qnrB, and qnrS among Clinical Isolates of Enterobacteriaceae in a Korean Hospital., Antimicrobial Agents and Chemotherapy, 52(11), 4159-4162.
  37. Yamane Kunikazu, Wachino Jun-ichi, Suzuki Satowa and Arakawa Yoshichika (2008)., Plasmid-Mediated qepA Gene among Escherichia coli Clinical Isolates from Japan., Antimicrobial Agents and Chemotherapy, 52(4), 1564-1566.
  38. Périchon Bruno, Courvalin Patrice and Galimand Marc (2007)., Transferable Resistance to Aminoglycosides by Methylation of G1405 in 16S rRNA and to Hydrophilic Fluoroquinolones by QepA-Mediated Efflux in Escherichia coli., Antimicrobial Agents and Chemotherapy, 51(7), 2464-2469.
  39. Zhou Tieli, Zhang Yapei, Li Meimei, Yu Xiao, Sun Yao and Xu Jiru (2015)., An outbreak of infections caused by extensively drug-resistant Klebsiella pneumoniae strains during a short period of time in a Chinese teaching hospital: epidemiology study and molecular characteristics., Diagnostic Microbiology and Infectious Disease, 82(3), 240-244.
  40. Cavaco M.L. and Aarestrup F.M. (2009)., Evaluation of Quinolones for Use in Detection of Determinants ofAcquired Quinolone Resistance, Including the New Transmissible Resistance Mechanisms qnrA, qnrB, qnrS, and aac(6_)Ib-cr, in Escherichia coli and Salmonella enteric and Determinations of Wild-Type Distributions., Journal of Clinical Microbiology, 47(9), 2751-2758.
  41. Ruiz Elena, Sáenz Yolanda, Zarazaga Myriam, Rocha-Gracia Rosa, Martínez-Martínez Luis, Arlet Guillaume and Torres Carmen (2012)., qnr, aac(6′)-Ib-cr and qepA genes in Escherichia coli and Klebsiella spp.: genetic environments and plasmid and chromosomal location., Journal of Antimicrobial Chemotherapy, 67(4), 886-897.
  42. Guillard T., Cambau E., Chau F., Massias L., Champs de C. and Fantin B. (2013)., Ciprofloxacin Treatment Failure in a Murine Model of Pyelonephritis Due to an AAC(6’)-Ib-cr-Producing Escherichia coli Strain Susceptible to Ciprofloxacin In Vitro., Antimicrobial Agents and Chemotherapy, 57(12), 5830-5835.
  43. Chmelnitsky I., Hermesh O., Venezia S.N., Strahilevitz J. and Carmeli Y. (2009)., Detection of aac(6’)-Ib-cr in KPC-producing Klebsiella pneumoniae isolates from Tel Aviv, Israel., Journal of Antimicrobial Chemotherapy, 64(4), 718-722.
  44. Kang Hee Young, Tamang Migma Dorji, Seol Sung Yong and Kim Jungmin (2009)., Dissemination of Plasmid-mediated qnr, aac(6, Journal of Bacteriology and Virology, 39(3), 173-182.
  45. Kim Eun Sil, Jeong Jin-Yong, Jun Jae-Bum, Choi Sang-Ho, Lee Sang-Oh, Kim Mi-Na, Woo Jun Hee and Kim Yang Soo (2009)., Prevalence of aac(6)-Ib-cr Encoding a Ciprofloxacin-Modifying Enzyme among Entero-bacteriaceae Blood Isolates in Korea., Antimicrobial Agents and Chemotherapy, 53(6), 2643-2645.
  46. Cattoir Vincent, Poirel Laurent and Nordmann Patrice (2008)., Plasmid-Mediated Quinolone Resistance Pump QepA2 in an Escherichia coli Isolate from France., Antimicrobial Agents and Chemotherapy, 52(10), 3801-3804.
  47. Li Bin, Yi Yong, Wang Qi, Woo Patrick C.Y., Tan Lin, Jing Hua, Gao George F. and Liu Cui Hua (2012)., Analysis of Drug Resistance Determinants in Klebsiella pneumoniae Isolates from a Tertiary-Care Hospital in Beijing, China., Plos one., 7(7), 1-12.
  48. Magesh H., Kamatchi C., Vaidyanathan R. and Sumathi G. (2011)., Identification of plasmid-mediated quinolone resistance genes qnrA1, qnrB1 and aac(6, Indian Journal of Medical Microbiology, 29(3), 262-268.
  49. Tripathi A., Dutta S.K., Majumdar M., Dhara L., Banerjee D. and Roy K. (2012)., High Prevalence and Significant Association of ESBL and QNR Genes in Pathogenic Klebsiella pneumoniae Isolates of Patients from Kolkata, India., Indian Journal of Microbiology, 52(4), 557-564.
  50. Brisse S., Milatovic D., Fluit A.C., Verhoef J. and Schmitz F.J. (2000)., Epidemiology of Quinolone Resistance of Klebsiella pneumoniae and Klebsiella oxytoca in Europe., Eur Journal of Clinical Microbiology Infectious Disease, 19(1), 64-68.
  51. Donnarumma F., Indorato C., Mastromei G., Goti E., Nicoletti P., Fanci R., Bosi A., Casalone E. and Pecile P. (2012)., Molecular analysis of population structure and antibiotic resistance of Klebsiella isolates from a three-year surveillance program in Florence hospitals, Italy., Eur Journal of Clinical Microbiology Infectious Disease, 31(3), 371-378.
  52. CLSI AST: Performance standards for Antimicrobial Susceptibility Testing: Twentieth Informational Supplement. CLSI document. M100-S26. Pennsylvania; Clinical and Laboratory Standards Institute. 2016., undefined, undefined
  53. Aathithan S. and French L.G. (2011)., Prevalence and role of efflux pump activity in ciprofloxacin resistance in clinical isolates of Klebsiella pneumoniae., Eur. Journal of Clinical Microbiology Infectious Disease, 30(6), 745-752.
  54. Cavaco M.L. and Aarestrup M.F. (2009)., Evaluation of Quinolones for Use in Detection of Determinants of Acquired Quinolone Resistance, Including the New Transmissible Resistance Mechanisms qnrA, qnrB, qnrS, and aac(6_)Ib-cr, in Escherichia coli and Salmonella enterica and Determinations of Wild-Type Distributions., Journal of Clinical Microbiology, 47(9), 2751-2758.
  55. Rosen D.A., Pinkner J.S., Walker J.N., Elam J.S., Jones J.M. and Hultgren S.J. (2008)., Molecular Variations in Klebsiella pneumoniae and Escherichia coli FimH Affect Function and Pathogenesis in the Urinary Tract., Infection and Immunity, 76(7), 3346-3356.
  56. Lotfi Ghellai, Hafida Hassaine, Nihel Klouche, Abdelmonaim Khadir, Nadia Aissaoui, Fatima Nas and Walter Zingg (2014)., Detection of biofilm formation of a collection of fifty strains of Staphylococcus aureus isolated in Algeria at the University Hospital of Tlemcen., Journal of Bacteriology Research, 6(1), 1-6.
  57. Guillard Thomas, Moret Hélène, Brasme Lucien, Carlier Antoine, Vernet-Garnier Véronique, Cambau Emmanuelle and Champs Christophe de (2011)., Rapid detection of qnr and qepA plasmid-mediated quinolone resistance genes using real-time PCR., Diagnostic Microbiology and Infectious Disease, 70(2), 253-259.